paraffin embedded tissue microarray sections Search Results


92
U.S Biomax Inc normal breast tissue array us biomax brn801 left
Normal Breast Tissue Array Us Biomax Brn801 Left, supplied by U.S Biomax Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/paraffin+embedded+tissue+microarray+sections/Breast+normal+tissue+with+breast+cancer+tissue+array%2C+including+pathology+grade%2C+TNM+and+clinical+stage%2C+80+cases%2F80+cores%2C+replacing+BRN801b/pmc03177013-58-0-4
Average 92 stars, based on 1 article reviews
normal breast tissue array us biomax brn801 left - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

90
Indivumed gmbh paraffin-embedded colorectal tissue microarray (tma
(A) Baseline expression of selected DDR markers was demonstrated and quantified in a <t>colorectal</t> tissue array with 32 tumors (2 cores per case are included) and 15 normal colon tissues. At least 500 individual tumor nuclei were quantified in 95% of the tissue <t>microarray</t> cores. (B-C) Baseline marker quantitation in advanced stage colorectal cancers from patients enrolled in Phase 1 clinical trials at NCI. Median expression and inter-quantile range is indicated for each marker. A minimum of 4,000 individual tumor nuclei were quantitated across at least two nonadjacent slides per biopsy specimen. (D) Baseline expression in human colon adenocarcinoma patient-derived xenografts. At least 5,000 nuclei quantified per model. (E) Baseline expression of selected DDR markers was demonstrated and quantified in 8 colorectal cancer cell lines. Over 1000 individual nuclei were quantified for each cell line. (F) Inter-lesion baseline Rad51 quantitation from patients with advanced stage cancers with two biopsies each collected from the same lesion. *p< 0.05. The dashed line represents our empirically determined baseline value cutoff of 5% of cells ≥ 5 Rad51 foci per nucleus.
Paraffin Embedded Colorectal Tissue Microarray (Tma, supplied by Indivumed gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/paraffin+embedded+tissue+microarray+sections/paraffin+embedded+colorectal+tissue+microarray++tma/pmc06522288-179-22-26
Average 90 stars, based on 1 article reviews
paraffin-embedded colorectal tissue microarray (tma - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Biomax Inc paraffin-embedded human liver disease progression tissue microarray slides
(A) Baseline expression of selected DDR markers was demonstrated and quantified in a <t>colorectal</t> tissue array with 32 tumors (2 cores per case are included) and 15 normal colon tissues. At least 500 individual tumor nuclei were quantified in 95% of the tissue <t>microarray</t> cores. (B-C) Baseline marker quantitation in advanced stage colorectal cancers from patients enrolled in Phase 1 clinical trials at NCI. Median expression and inter-quantile range is indicated for each marker. A minimum of 4,000 individual tumor nuclei were quantitated across at least two nonadjacent slides per biopsy specimen. (D) Baseline expression in human colon adenocarcinoma patient-derived xenografts. At least 5,000 nuclei quantified per model. (E) Baseline expression of selected DDR markers was demonstrated and quantified in 8 colorectal cancer cell lines. Over 1000 individual nuclei were quantified for each cell line. (F) Inter-lesion baseline Rad51 quantitation from patients with advanced stage cancers with two biopsies each collected from the same lesion. *p< 0.05. The dashed line represents our empirically determined baseline value cutoff of 5% of cells ≥ 5 Rad51 foci per nucleus.
Paraffin Embedded Human Liver Disease Progression Tissue Microarray Slides, supplied by Biomax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/paraffin+embedded+tissue+microarray+sections/paraffin+embedded+human+liver+disease+progression+tissue+microarray+slides/10__1158_slash_0008___5472__can___16___2200-54-1-11
Average 90 stars, based on 1 article reviews
paraffin-embedded human liver disease progression tissue microarray slides - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Biomax Inc paraffin-embedded human bladder tissue microarray slides blc1501
(A) Baseline expression of selected DDR markers was demonstrated and quantified in a <t>colorectal</t> tissue array with 32 tumors (2 cores per case are included) and 15 normal colon tissues. At least 500 individual tumor nuclei were quantified in 95% of the tissue <t>microarray</t> cores. (B-C) Baseline marker quantitation in advanced stage colorectal cancers from patients enrolled in Phase 1 clinical trials at NCI. Median expression and inter-quantile range is indicated for each marker. A minimum of 4,000 individual tumor nuclei were quantitated across at least two nonadjacent slides per biopsy specimen. (D) Baseline expression in human colon adenocarcinoma patient-derived xenografts. At least 5,000 nuclei quantified per model. (E) Baseline expression of selected DDR markers was demonstrated and quantified in 8 colorectal cancer cell lines. Over 1000 individual nuclei were quantified for each cell line. (F) Inter-lesion baseline Rad51 quantitation from patients with advanced stage cancers with two biopsies each collected from the same lesion. *p< 0.05. The dashed line represents our empirically determined baseline value cutoff of 5% of cells ≥ 5 Rad51 foci per nucleus.
Paraffin Embedded Human Bladder Tissue Microarray Slides Blc1501, supplied by Biomax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/paraffin+embedded+tissue+microarray+sections/paraffin+embedded+human+bladder+tissue+microarray+slides+blc1501/pm36862682-101-13-23
Average 90 stars, based on 1 article reviews
paraffin-embedded human bladder tissue microarray slides blc1501 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Nuclea Biotechnologies clinically annotated tissue microarray (tma) slides
(A) Baseline expression of selected DDR markers was demonstrated and quantified in a <t>colorectal</t> tissue array with 32 tumors (2 cores per case are included) and 15 normal colon tissues. At least 500 individual tumor nuclei were quantified in 95% of the tissue <t>microarray</t> cores. (B-C) Baseline marker quantitation in advanced stage colorectal cancers from patients enrolled in Phase 1 clinical trials at NCI. Median expression and inter-quantile range is indicated for each marker. A minimum of 4,000 individual tumor nuclei were quantitated across at least two nonadjacent slides per biopsy specimen. (D) Baseline expression in human colon adenocarcinoma patient-derived xenografts. At least 5,000 nuclei quantified per model. (E) Baseline expression of selected DDR markers was demonstrated and quantified in 8 colorectal cancer cell lines. Over 1000 individual nuclei were quantified for each cell line. (F) Inter-lesion baseline Rad51 quantitation from patients with advanced stage cancers with two biopsies each collected from the same lesion. *p< 0.05. The dashed line represents our empirically determined baseline value cutoff of 5% of cells ≥ 5 Rad51 foci per nucleus.
Clinically Annotated Tissue Microarray (Tma) Slides, supplied by Nuclea Biotechnologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/paraffin+embedded+tissue+microarray+sections/clinically+annotated+tissue+microarray++tma++formalin+fixed++paraffin+embedded++ffpe++slides/pm36831366-293-2-19
Average 90 stars, based on 1 article reviews
clinically annotated tissue microarray (tma) slides - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
BioConsult paraffinized patient-derived tissue sections containing microarrays
(A) Baseline expression of selected DDR markers was demonstrated and quantified in a <t>colorectal</t> tissue array with 32 tumors (2 cores per case are included) and 15 normal colon tissues. At least 500 individual tumor nuclei were quantified in 95% of the tissue <t>microarray</t> cores. (B-C) Baseline marker quantitation in advanced stage colorectal cancers from patients enrolled in Phase 1 clinical trials at NCI. Median expression and inter-quantile range is indicated for each marker. A minimum of 4,000 individual tumor nuclei were quantitated across at least two nonadjacent slides per biopsy specimen. (D) Baseline expression in human colon adenocarcinoma patient-derived xenografts. At least 5,000 nuclei quantified per model. (E) Baseline expression of selected DDR markers was demonstrated and quantified in 8 colorectal cancer cell lines. Over 1000 individual nuclei were quantified for each cell line. (F) Inter-lesion baseline Rad51 quantitation from patients with advanced stage cancers with two biopsies each collected from the same lesion. *p< 0.05. The dashed line represents our empirically determined baseline value cutoff of 5% of cells ≥ 5 Rad51 foci per nucleus.
Paraffinized Patient Derived Tissue Sections Containing Microarrays, supplied by BioConsult, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/paraffin+embedded+tissue+microarray+sections/paraffinized+patient+derived+tissue+sections+containing+microarrays/pmc09556484-158-5-9
Average 90 stars, based on 1 article reviews
paraffinized patient-derived tissue sections containing microarrays - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
U.S Biomax Inc tissue microarray (tma) containing paraffin-embedded normal and malignant lung tissues
(A) Baseline expression of selected DDR markers was demonstrated and quantified in a <t>colorectal</t> tissue array with 32 tumors (2 cores per case are included) and 15 normal colon tissues. At least 500 individual tumor nuclei were quantified in 95% of the tissue <t>microarray</t> cores. (B-C) Baseline marker quantitation in advanced stage colorectal cancers from patients enrolled in Phase 1 clinical trials at NCI. Median expression and inter-quantile range is indicated for each marker. A minimum of 4,000 individual tumor nuclei were quantitated across at least two nonadjacent slides per biopsy specimen. (D) Baseline expression in human colon adenocarcinoma patient-derived xenografts. At least 5,000 nuclei quantified per model. (E) Baseline expression of selected DDR markers was demonstrated and quantified in 8 colorectal cancer cell lines. Over 1000 individual nuclei were quantified for each cell line. (F) Inter-lesion baseline Rad51 quantitation from patients with advanced stage cancers with two biopsies each collected from the same lesion. *p< 0.05. The dashed line represents our empirically determined baseline value cutoff of 5% of cells ≥ 5 Rad51 foci per nucleus.
Tissue Microarray (Tma) Containing Paraffin Embedded Normal And Malignant Lung Tissues, supplied by U.S Biomax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/paraffin+embedded+tissue+microarray+sections/tissue+microarray++tma++containing+paraffin+embedded+normal+and+malignant+lung+tissues/pmc06995575-37-30-33
Average 90 stars, based on 1 article reviews
tissue microarray (tma) containing paraffin-embedded normal and malignant lung tissues - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Shanghai Biochip Co. Ltd paraffin-embedded kirc tissue microarrays (no. hkide180su02)
a Pearson correlation analysis of the relationship between CDKN2B-AS1 and IGF2BP3 levels in <t>TCGA-KIRC</t> dataset. Normal tissues are shown as blue circles ( n = 72) and tumor tissues as red circles ( n = 533). b – e 769-P and ACHN cells were treated with si-IGF2BP3 for 48 h; qRT-PCR analysis of IGF2BP3, CDKN2B-AS1, and NUF2 expression with β-actin as the internal control ( b ); western blot analysis of IGF2BP3 and NUF2 protein levels with GAPDH as the internal control ( c ); qRT-PCR analysis of CDKN2B-AS1 ( d ) and NUF2 mRNA ( e ) stability, RNA levels were measured after treatment with actinomycin D (5 μg/mL) for 0, 2, 4, 8, 12, and 24 h, respectively, and compared to the level at 0 h. f RIP assay analysis of IGF2BP3 enrichment in CDKN2B-AS1, NUF2, and Linc01138 in 769-P and ACHN cells; RIP enrichment was measured using qRT-PCR normalized by the input RNA. g Colony formation assays were performed to assess cell proliferation in 769-P and ACHN cells treated with si-IGF2BP3. h Transwell assays were used to evaluate migration and invasion in 769-P and ACHN cells transfected with si-IGF2BP3. Scale bar: 50 μm. i , j Immunostaining score of IGF2BP3 in immunohistochemistry of patients with a different histologic grade ( i ) and TNM stage ( j ) from the paraffin-embedded KIRC tissue microarray (No. <t>HkidE180Su02).</t> k , l Kaplan–Meier analysis showed the overall survival and disease-free survival in KIRC patients based on the expression of IGF2BP3 in TCGA dataset; the high and low expression groups were divided by the median of IGF2BP3 levels. Error bars represent the SEM from at least three independent experiments, ** p < 0.01 vs. si-NC or anti-IgG, * p < 0.05 vs. si-NC or anti-IgG. ns. no significance ( p > 0.05). P value calculated by independent sample t test ( b – j ), or log-rank test ( k , l ).
Paraffin Embedded Kirc Tissue Microarrays (No. Hkide180su02), supplied by Shanghai Biochip Co. Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/paraffin+embedded+tissue+microarray+sections/paraffin+embedded+kirc+tissue+microarrays++no++hkide180su02+/pmc07895987-91-1-9
Average 90 stars, based on 1 article reviews
paraffin-embedded kirc tissue microarrays (no. hkide180su02) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
U.S Biomax Inc paraffin-embedded serial breast tissue microarray
IR-OH imaging of breast tissue and spectral cell type recognition. (A) H&E image of a breast tissue <t>microarray</t> section. (Scale bar: 500 μm.) (B) IR-OH absorption of an adjacent, unstained tissue section (at 1,550 cm−1). (C) A four-class model (blood, epithelium, stroma, and other) allows rapid tissue component visualization based on five IR bands. (D) Epithelial classification (five-class model) permits both histologic cellular identification and recognition of cancer based on seven IR bands. (E) ROC curves quantify the accuracy of recognition in D by IR-OH. (F) AUC of the ROC curve increases with number of IR frequencies used for classification, showing a small number provides good recognition (G and H) Representative class spectra obtained with IR-OH and FT-IR imaging. Full classification maps are shown in SI Appendix, Figs. S3 and S4. Class mean spectra and variance are shown in SI Appendix, Figs. S5 and S6, and further AUC and ROC curves are shown in SI Appendix, Fig. S7.
Paraffin Embedded Serial Breast Tissue Microarray, supplied by U.S Biomax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/paraffin+embedded+tissue+microarray+sections/Breast+normal+tissue+with+breast+cancer+tissue+array%2C+including+pathology+grade%2C+TNM+and+clinical+stage%2C+80+cases%2F80+cores%2C+replacing+BRN801b/pmc07035604-266-3-7
Average 90 stars, based on 1 article reviews
paraffin-embedded serial breast tissue microarray - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
U.S Biomax Inc formalin-fixed and embedded 402 paraffin blocks of neuroblastoma patient tissue microarray (#nb642a)
IR-OH imaging of breast tissue and spectral cell type recognition. (A) H&E image of a breast tissue <t>microarray</t> section. (Scale bar: 500 μm.) (B) IR-OH absorption of an adjacent, unstained tissue section (at 1,550 cm−1). (C) A four-class model (blood, epithelium, stroma, and other) allows rapid tissue component visualization based on five IR bands. (D) Epithelial classification (five-class model) permits both histologic cellular identification and recognition of cancer based on seven IR bands. (E) ROC curves quantify the accuracy of recognition in D by IR-OH. (F) AUC of the ROC curve increases with number of IR frequencies used for classification, showing a small number provides good recognition (G and H) Representative class spectra obtained with IR-OH and FT-IR imaging. Full classification maps are shown in SI Appendix, Figs. S3 and S4. Class mean spectra and variance are shown in SI Appendix, Figs. S5 and S6, and further AUC and ROC curves are shown in SI Appendix, Fig. S7.
Formalin Fixed And Embedded 402 Paraffin Blocks Of Neuroblastoma Patient Tissue Microarray (#Nb642a), supplied by U.S Biomax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/paraffin+embedded+tissue+microarray+sections/formalin+fixed+and+embedded+402+paraffin+blocks+of+neuroblastoma+patient+tissue+microarray+++nb642a+/10__1016_slash_j__omtn__2022__03__014-180-8-16
Average 90 stars, based on 1 article reviews
formalin-fixed and embedded 402 paraffin blocks of neuroblastoma patient tissue microarray (#nb642a) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
TissueArray.com LLC paraffin-embedded tissue microarrays (tmas) of formalin-fixed human osteosarcoma and various normal tissues
IR-OH imaging of breast tissue and spectral cell type recognition. (A) H&E image of a breast tissue <t>microarray</t> section. (Scale bar: 500 μm.) (B) IR-OH absorption of an adjacent, unstained tissue section (at 1,550 cm−1). (C) A four-class model (blood, epithelium, stroma, and other) allows rapid tissue component visualization based on five IR bands. (D) Epithelial classification (five-class model) permits both histologic cellular identification and recognition of cancer based on seven IR bands. (E) ROC curves quantify the accuracy of recognition in D by IR-OH. (F) AUC of the ROC curve increases with number of IR frequencies used for classification, showing a small number provides good recognition (G and H) Representative class spectra obtained with IR-OH and FT-IR imaging. Full classification maps are shown in SI Appendix, Figs. S3 and S4. Class mean spectra and variance are shown in SI Appendix, Figs. S5 and S6, and further AUC and ROC curves are shown in SI Appendix, Fig. S7.
Paraffin Embedded Tissue Microarrays (Tmas) Of Formalin Fixed Human Osteosarcoma And Various Normal Tissues, supplied by TissueArray.com LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/paraffin+embedded+tissue+microarray+sections/paraffin+embedded+tissue+microarrays++tmas++of+formalin+fixed+human+osteosarcoma+and+various+normal+tissues/pmc11121324-127-0-15
Average 90 stars, based on 1 article reviews
paraffin-embedded tissue microarrays (tmas) of formalin-fixed human osteosarcoma and various normal tissues - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
U.S Biomax Inc unstained slides formalin fixed, paraffin embedded tissue microarray (tma) blocks
IR-OH imaging of breast tissue and spectral cell type recognition. (A) H&E image of a breast tissue <t>microarray</t> section. (Scale bar: 500 μm.) (B) IR-OH absorption of an adjacent, unstained tissue section (at 1,550 cm−1). (C) A four-class model (blood, epithelium, stroma, and other) allows rapid tissue component visualization based on five IR bands. (D) Epithelial classification (five-class model) permits both histologic cellular identification and recognition of cancer based on seven IR bands. (E) ROC curves quantify the accuracy of recognition in D by IR-OH. (F) AUC of the ROC curve increases with number of IR frequencies used for classification, showing a small number provides good recognition (G and H) Representative class spectra obtained with IR-OH and FT-IR imaging. Full classification maps are shown in SI Appendix, Figs. S3 and S4. Class mean spectra and variance are shown in SI Appendix, Figs. S5 and S6, and further AUC and ROC curves are shown in SI Appendix, Fig. S7.
Unstained Slides Formalin Fixed, Paraffin Embedded Tissue Microarray (Tma) Blocks, supplied by U.S Biomax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/paraffin+embedded+tissue+microarray+sections/unstained+slides+formalin+fixed++paraffin+embedded+tissue+microarray++tma++blocks/pmc05675809-89-0-12
Average 90 stars, based on 1 article reviews
unstained slides formalin fixed, paraffin embedded tissue microarray (tma) blocks - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


(A) Baseline expression of selected DDR markers was demonstrated and quantified in a colorectal tissue array with 32 tumors (2 cores per case are included) and 15 normal colon tissues. At least 500 individual tumor nuclei were quantified in 95% of the tissue microarray cores. (B-C) Baseline marker quantitation in advanced stage colorectal cancers from patients enrolled in Phase 1 clinical trials at NCI. Median expression and inter-quantile range is indicated for each marker. A minimum of 4,000 individual tumor nuclei were quantitated across at least two nonadjacent slides per biopsy specimen. (D) Baseline expression in human colon adenocarcinoma patient-derived xenografts. At least 5,000 nuclei quantified per model. (E) Baseline expression of selected DDR markers was demonstrated and quantified in 8 colorectal cancer cell lines. Over 1000 individual nuclei were quantified for each cell line. (F) Inter-lesion baseline Rad51 quantitation from patients with advanced stage cancers with two biopsies each collected from the same lesion. *p< 0.05. The dashed line represents our empirically determined baseline value cutoff of 5% of cells ≥ 5 Rad51 foci per nucleus.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Article Title: Evaluation of pharmacodynamic responses to cancer therapeutic agents using DNA damage markers

doi: 10.1158/1078-0432.CCR-18-2523

Figure Lengend Snippet: (A) Baseline expression of selected DDR markers was demonstrated and quantified in a colorectal tissue array with 32 tumors (2 cores per case are included) and 15 normal colon tissues. At least 500 individual tumor nuclei were quantified in 95% of the tissue microarray cores. (B-C) Baseline marker quantitation in advanced stage colorectal cancers from patients enrolled in Phase 1 clinical trials at NCI. Median expression and inter-quantile range is indicated for each marker. A minimum of 4,000 individual tumor nuclei were quantitated across at least two nonadjacent slides per biopsy specimen. (D) Baseline expression in human colon adenocarcinoma patient-derived xenografts. At least 5,000 nuclei quantified per model. (E) Baseline expression of selected DDR markers was demonstrated and quantified in 8 colorectal cancer cell lines. Over 1000 individual nuclei were quantified for each cell line. (F) Inter-lesion baseline Rad51 quantitation from patients with advanced stage cancers with two biopsies each collected from the same lesion. *p< 0.05. The dashed line represents our empirically determined baseline value cutoff of 5% of cells ≥ 5 Rad51 foci per nucleus.

Article Snippet: Baseline biological variability was established for each biomarker across 64 individual cores from 32 colorectal (CRC) tumor resections contained in a paraffin-embedded colorectal tissue microarray (TMA; Indivumed, Hamburg, Germany).

Techniques: Expressing, Microarray, Marker, Quantitation Assay, Derivative Assay

Representative H&E and immunofluorescence (IFA) images from 3 patients with advanced colorectal cancer enrolled in NCI trial NCT01851369 before and 5 days after start of treatment with a DNA damaging therapeutic regimen consisting of TCR102 plus temozolomide administered orally once daily. Red scale bar represents 10 μm.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Article Title: Evaluation of pharmacodynamic responses to cancer therapeutic agents using DNA damage markers

doi: 10.1158/1078-0432.CCR-18-2523

Figure Lengend Snippet: Representative H&E and immunofluorescence (IFA) images from 3 patients with advanced colorectal cancer enrolled in NCI trial NCT01851369 before and 5 days after start of treatment with a DNA damaging therapeutic regimen consisting of TCR102 plus temozolomide administered orally once daily. Red scale bar represents 10 μm.

Article Snippet: Baseline biological variability was established for each biomarker across 64 individual cores from 32 colorectal (CRC) tumor resections contained in a paraffin-embedded colorectal tissue microarray (TMA; Indivumed, Hamburg, Germany).

Techniques: Immunofluorescence

a Pearson correlation analysis of the relationship between CDKN2B-AS1 and IGF2BP3 levels in TCGA-KIRC dataset. Normal tissues are shown as blue circles ( n = 72) and tumor tissues as red circles ( n = 533). b – e 769-P and ACHN cells were treated with si-IGF2BP3 for 48 h; qRT-PCR analysis of IGF2BP3, CDKN2B-AS1, and NUF2 expression with β-actin as the internal control ( b ); western blot analysis of IGF2BP3 and NUF2 protein levels with GAPDH as the internal control ( c ); qRT-PCR analysis of CDKN2B-AS1 ( d ) and NUF2 mRNA ( e ) stability, RNA levels were measured after treatment with actinomycin D (5 μg/mL) for 0, 2, 4, 8, 12, and 24 h, respectively, and compared to the level at 0 h. f RIP assay analysis of IGF2BP3 enrichment in CDKN2B-AS1, NUF2, and Linc01138 in 769-P and ACHN cells; RIP enrichment was measured using qRT-PCR normalized by the input RNA. g Colony formation assays were performed to assess cell proliferation in 769-P and ACHN cells treated with si-IGF2BP3. h Transwell assays were used to evaluate migration and invasion in 769-P and ACHN cells transfected with si-IGF2BP3. Scale bar: 50 μm. i , j Immunostaining score of IGF2BP3 in immunohistochemistry of patients with a different histologic grade ( i ) and TNM stage ( j ) from the paraffin-embedded KIRC tissue microarray (No. HkidE180Su02). k , l Kaplan–Meier analysis showed the overall survival and disease-free survival in KIRC patients based on the expression of IGF2BP3 in TCGA dataset; the high and low expression groups were divided by the median of IGF2BP3 levels. Error bars represent the SEM from at least three independent experiments, ** p < 0.01 vs. si-NC or anti-IgG, * p < 0.05 vs. si-NC or anti-IgG. ns. no significance ( p > 0.05). P value calculated by independent sample t test ( b – j ), or log-rank test ( k , l ).

Journal: Cell Death & Disease

Article Title: LncRNA CDKN2B-AS1 stabilized by IGF2BP3 drives the malignancy of renal clear cell carcinoma through epigenetically activating NUF2 transcription

doi: 10.1038/s41419-021-03489-y

Figure Lengend Snippet: a Pearson correlation analysis of the relationship between CDKN2B-AS1 and IGF2BP3 levels in TCGA-KIRC dataset. Normal tissues are shown as blue circles ( n = 72) and tumor tissues as red circles ( n = 533). b – e 769-P and ACHN cells were treated with si-IGF2BP3 for 48 h; qRT-PCR analysis of IGF2BP3, CDKN2B-AS1, and NUF2 expression with β-actin as the internal control ( b ); western blot analysis of IGF2BP3 and NUF2 protein levels with GAPDH as the internal control ( c ); qRT-PCR analysis of CDKN2B-AS1 ( d ) and NUF2 mRNA ( e ) stability, RNA levels were measured after treatment with actinomycin D (5 μg/mL) for 0, 2, 4, 8, 12, and 24 h, respectively, and compared to the level at 0 h. f RIP assay analysis of IGF2BP3 enrichment in CDKN2B-AS1, NUF2, and Linc01138 in 769-P and ACHN cells; RIP enrichment was measured using qRT-PCR normalized by the input RNA. g Colony formation assays were performed to assess cell proliferation in 769-P and ACHN cells treated with si-IGF2BP3. h Transwell assays were used to evaluate migration and invasion in 769-P and ACHN cells transfected with si-IGF2BP3. Scale bar: 50 μm. i , j Immunostaining score of IGF2BP3 in immunohistochemistry of patients with a different histologic grade ( i ) and TNM stage ( j ) from the paraffin-embedded KIRC tissue microarray (No. HkidE180Su02). k , l Kaplan–Meier analysis showed the overall survival and disease-free survival in KIRC patients based on the expression of IGF2BP3 in TCGA dataset; the high and low expression groups were divided by the median of IGF2BP3 levels. Error bars represent the SEM from at least three independent experiments, ** p < 0.01 vs. si-NC or anti-IgG, * p < 0.05 vs. si-NC or anti-IgG. ns. no significance ( p > 0.05). P value calculated by independent sample t test ( b – j ), or log-rank test ( k , l ).

Article Snippet: Paraffin-embedded KIRC tissue microarrays (No. HkidE180Su02) were purchased from Shanghai Biochip Company Ltd. (Shanghai, China).

Techniques: Quantitative RT-PCR, Expressing, Western Blot, Migration, Transfection, Immunostaining, Immunohistochemistry, Microarray

IR-OH imaging of breast tissue and spectral cell type recognition. (A) H&E image of a breast tissue microarray section. (Scale bar: 500 μm.) (B) IR-OH absorption of an adjacent, unstained tissue section (at 1,550 cm−1). (C) A four-class model (blood, epithelium, stroma, and other) allows rapid tissue component visualization based on five IR bands. (D) Epithelial classification (five-class model) permits both histologic cellular identification and recognition of cancer based on seven IR bands. (E) ROC curves quantify the accuracy of recognition in D by IR-OH. (F) AUC of the ROC curve increases with number of IR frequencies used for classification, showing a small number provides good recognition (G and H) Representative class spectra obtained with IR-OH and FT-IR imaging. Full classification maps are shown in SI Appendix, Figs. S3 and S4. Class mean spectra and variance are shown in SI Appendix, Figs. S5 and S6, and further AUC and ROC curves are shown in SI Appendix, Fig. S7.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: All-digital histopathology by infrared-optical hybrid microscopy

doi: 10.1073/pnas.1912400117

Figure Lengend Snippet: IR-OH imaging of breast tissue and spectral cell type recognition. (A) H&E image of a breast tissue microarray section. (Scale bar: 500 μm.) (B) IR-OH absorption of an adjacent, unstained tissue section (at 1,550 cm−1). (C) A four-class model (blood, epithelium, stroma, and other) allows rapid tissue component visualization based on five IR bands. (D) Epithelial classification (five-class model) permits both histologic cellular identification and recognition of cancer based on seven IR bands. (E) ROC curves quantify the accuracy of recognition in D by IR-OH. (F) AUC of the ROC curve increases with number of IR frequencies used for classification, showing a small number provides good recognition (G and H) Representative class spectra obtained with IR-OH and FT-IR imaging. Full classification maps are shown in SI Appendix, Figs. S3 and S4. Class mean spectra and variance are shown in SI Appendix, Figs. S5 and S6, and further AUC and ROC curves are shown in SI Appendix, Fig. S7.

Article Snippet: A paraffin-embedded serial breast tissue microarray (BR1003a; US Biomax Inc.) consisting of a total of 101 cores of nominal 1 mm diameter from 47 cases was obtained.

Techniques: Imaging, Microarray